ArticleOncotarget2017

Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors.

Eusebio S Pires et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.